S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CSCI COSCIENS Biopharma Inc

2.72

-0.06 (-2.16%)

Last Updated: 01:30:03

Delayed by 15 minutes

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Article too big to display. Click here to view on the SEC website

COSCIENS Biopharma (NASDAQ:CSCI)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more COSCIENS Biopharma Charts.

COSCIENS Biopharma (NASDAQ:CSCI)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more COSCIENS Biopharma Charts.

COSCIENS Biopharma Inc News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization
Monday 23 December 2024 (2 months ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Saturday 21 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs
Tuesday 12 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 8 October 2024 (5 months ago) • Edgar (US Regulatory)

COSCIENS Biopharma Announces Change to Board of Directors
Tuesday 8 October 2024 (5 months ago) • GlobeNewswire Inc.

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director
Wednesday 2 October 2024 (5 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 2 October 2024 (5 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 23 September 2024 (5 months ago) • Edgar (US Regulatory)

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
Monday 23 September 2024 (5 months ago) • GlobeNewswire Inc.

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Saturday 7 September 2024 (6 months ago) • Edgar (US Regulatory)

More COSCIENS Biopharma Inc News Articles

First Trust Global Funds

Societe Generale Effekten

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions